This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Global Excipients Industry Is Expected To Reach USD 7,586.6 Million In 2018: Transparency Market Research

ALBANY, New York, November 7, 2012 /PRNewswire/ --

According to a new market report published by Transparency Market Research ( http://www.transparencymarketresearch.com) " Excipients Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast, 2012 - 2018," the global excipients demand was worth USD 5,260.0 million in 2011 and is expected to reach USD 7,586.6 million in 2018, growing at a CAGR of 5.4% from 2013 to 2018. Currently, Europe dominates the global market in terms of demand; however Asia Pacific is expected to be the most promising market in the near future mainly due to the availability of low cost products and cheap labor. The North America market for excipients in terms of revenue is growing at a CAGR of 5.3% from 2013 to 2018 as the U.S. has the biggest pharmaceutical market globally.

Browse the full report at  http://www.transparencymarketresearch.com/excipients-market.html

The demand for excipients is witnessing significant growth as it is considered as the functional additive in the pharmaceutical industry. Some of the factors driving the growth of the excipients market include increasing demand for novel excipients and growth in the global pharmaceuticals market. However, the market is being restrained due to the high cost of manufacturing, supply chain issues, and declining R&D investment.

In terms of products, the market is dominated by sugar and other applications which are primarily driven by its uses as fillers, diluents and tablet coating agents. The market for sugar and other products in terms of volumes is expected to grow at a CAGR of 5.1% from 2013 to 2018. Following sugar and other products, the market for alcohol and gelatin are also growing significantly.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs